Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory iIllness, South Africa, 2009–2010

dc.contributor.authorPretorius, Marthi Andréa
dc.contributor.authorMadhi, Shabir A.
dc.contributor.authorCohen, Cheryl
dc.contributor.authorNaidoo, Dhamari
dc.contributor.authorGroome, Michelle
dc.contributor.authorMoyes, Jocelyn
dc.contributor.authorBuys, Amelia
dc.contributor.authorWalaza, Sibongile
dc.contributor.authorDawood, Halima
dc.contributor.authorChhagan, Meera
dc.contributor.authorHaffejee, Summaya
dc.contributor.authorKahn, Kathleen
dc.contributor.authorPuren, Adrian
dc.contributor.authorVenter, Marietjie
dc.date.accessioned2013-05-30T06:35:56Z
dc.date.available2013-12-31T00:20:04Z
dc.date.issued2012
dc.description.abstractBACKGROUND: Data about respiratory co-infections of Influenza A H1N1 during the pandemic in Africa are limited. We used an existing surveillance programme for severe acute respiratory illness (SARI) to evaluate a new multiplex real-time polymerase chain reaction assay and investigate the role of influenza and other respiratory viruses in pneumonia hospitalisations during and after the influenza pandemic in South Africa. METHOD: The multiplex assay was developed to detect 10 respiratory viruses including Influenza (INF) A and B, Parainfluenza (PIV1-3), Respiratory Syncytial Virus (RSV), Enterovirus (EV), human metapneumovirus (hMPV), Adenovirus (AdV) and Rhinovirus (RV), followed by influenza subtyping. Nasopharyngeal and oropharyngeal specimens were collected from patients hospitalized with pneumonia at six hospitals during 2009–2010. RESULTS: Validation against external quality controls confirmed the high sensitivity (91%) and specificity (100%) and user-friendliness when compared to other PCR technologies. Of 8173 patients, 40% had single-infections, 17% co-infections and 43% remained negative. The most common viruses were: RV (25%), RSV (14%), AdV (13%), Influenza A (5%). Influenza, RSV, PIV3 and hMPV showed seasonal patterns. CONCLUSION: The data provide a better understanding of the viral aetiology of hospitalized cases of pneumonia and demonstrate the usefulness of this multiplex assay in respiratory disease surveillance in South Africa.en_US
dc.description.librarianhb2013en_US
dc.description.sponsorshipFunding provided by co-operative agreement 5U51/IP000155 with the Centers for Disease Control and Prevention, Atlanta, Georgia, USA.en_US
dc.description.urihttp://www.journals.uchicago.edu/toc/jid/currenten_US
dc.identifier.citationPretorius, MA ... et al. 2012, 'Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory iIllness, South Africa, 2009–2010', Journal of Infectious Diseases, vol. 206, Suppl., 1, pp. S159-S165.en_US
dc.identifier.issn0022-1899 (print)
dc.identifier.issn1537-6613 (online)
dc.identifier.other10.1093/infdis/jis538
dc.identifier.urihttp://hdl.handle.net/2263/21576
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.rights© The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.en_US
dc.subjectCo-infectionen_US
dc.subjectPandemic influenza H1N1en_US
dc.subjectMultiplex assayen_US
dc.subjectRespiratory virus infectionen_US
dc.subjectSevere acute respiratory illness (SARI)en_US
dc.subjectSouth Africaen_US
dc.titleRespiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory iIllness, South Africa, 2009–2010en_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pretorius_Respiratory_2012.pdf
Size:
1.58 MB
Format:
Adobe Portable Document Format
Description:
Postprint Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: